Essential thrombocytosis historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (25 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Essential thrombocytosis}} | {{Essential thrombocytosis}} | ||
{{CMG}} | {{CMG}}{{AE}} {{STM}} | ||
==Overview== | ==Overview== | ||
Essential thrombocytosis | Essential thrombocytosis was first defined by Emil Epstein and Alfred Goedel, two Austrian pathologists, in the year 1934 and was initially called [[hemorrhagic thrombocythemia]].<ref name=tt>{{Cite journal | ||
| author = [[Steven Sanchez]] & [[April Ewton]] | |||
| title = Essential thrombocythemia: a review of diagnostic and pathologic features | |||
| journal = [[Archives of pathology & laboratory medicine]] | |||
| volume = 130 | |||
| issue = 8 | |||
| pages = 1144–1150 | |||
| year = 2006 | |||
| month = August | |||
| pmid = 16879015 | |||
}}</ref> | |||
==Historical perspective== | ==Historical perspective== | ||
Essential thrombocytosis | *Essential thrombocytosis was first defined by Emil Epstein and Alfred Goedel, two Austrian pathologists, in the year 1934 and was initially called hemorrhagic thrombocythemia.<ref name=tt>{{Cite journal | ||
| author = [[Steven Sanchez]] & [[April Ewton]] | |||
| title = Essential thrombocythemia: a review of diagnostic and pathologic features | |||
| journal = [[Archives of pathology & laboratory medicine]] | |||
| volume = 130 | |||
| issue = 8 | |||
| pages = 1144–1150 | |||
| year = 2006 | |||
| month = August | |||
| pmid = 16879015 | |||
}}</ref> | |||
*Subsequently, essential thrombocytosis was classified as a myeloproliferative disorder along with [[chronic myelogenous leukemia]] ([[CML]]), [[polycythemia vera]] (PV), and chronic idiopathic [[myelofibrosis]] (CIMF). | |||
==References== | ==References== | ||
Latest revision as of 14:40, 6 January 2016
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis historical perspective |
|
Risk calculators and risk factors for Essential thrombocytosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Essential thrombocytosis was first defined by Emil Epstein and Alfred Goedel, two Austrian pathologists, in the year 1934 and was initially called hemorrhagic thrombocythemia.[1]
Historical perspective
- Essential thrombocytosis was first defined by Emil Epstein and Alfred Goedel, two Austrian pathologists, in the year 1934 and was initially called hemorrhagic thrombocythemia.[1]
- Subsequently, essential thrombocytosis was classified as a myeloproliferative disorder along with chronic myelogenous leukemia (CML), polycythemia vera (PV), and chronic idiopathic myelofibrosis (CIMF).
References
- ↑ 1.0 1.1 Steven Sanchez & April Ewton (2006). "Essential thrombocythemia: a review of diagnostic and pathologic features". Archives of pathology & laboratory medicine. 130 (8): 1144–1150. PMID 16879015. Unknown parameter
|month=ignored (help)